Applied Therapeutics Inc (APLT) concluded trading on Thursday at a closing price of $0.61, with 4.77 million shares of worth about $2.91 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -88.60% during that period and on January 23, 2025 the price saw a loss of about -2.98%. Currently the company’s common shares owned by public are about 116.36M shares, out of which, 86.61M shares are available for trading.
Stock saw a price change of -7.51% in past 5 days and over the past one month there was a price change of -40.23%. Year-to-date (YTD), APLT shares are showing a performance of -28.79% which decreased to -77.83% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.60 but also hit the highest price of $10.62 during that period. The average intraday trading volume for Applied Therapeutics Inc shares is 6.80 million. The stock is currently trading -19.82% below its 20-day simple moving average (SMA20), while that difference is down -81.74% for SMA50 and it goes to -88.45% lower than SMA200.
Applied Therapeutics Inc (NASDAQ: APLT) currently have 116.36M outstanding shares and institutions hold larger chunk of about 88.10% of that.
The stock has a current market capitalization of $70.94M and its 3Y-monthly beta is at 1.87. It has Quick Ratio of 1.06 while making debt-to-equity ratio of 0.33. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for APLT, volatility over the week remained 12.87% while standing at 13.22% over the month.
Analysts are in expectations that Applied Therapeutics Inc (APLT) stock would likely to be making an EPS of -0.19 in the current quarter, while forecast for next quarter EPS is -0.16 and it is -0.48 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.27 which is -0.13 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.33 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 1.41% while it is estimated to increase by 58.08% in next year.
Coverage by UBS stated Applied Therapeutics Inc (APLT) stock as a Neutral in their note to investors on December 02, 2024, suggesting a price target of $2 for the stock. Stock get an Outperform rating from RBC Capital Mkts on March 26, 2024.
